Spesifikasi
(Out of Specification)
TOPICS
Laporan Investigasi
Disposisi Produk
Hasil tes yang berada diluar spesifikasi atau kriteria penerimaan yang
ditetapkan dalam dossier/dokumen yang di ajukan ke BPOM/Authorithy,
file induk obat (Drug Master file), farmakope atau spesifikasi internal.
A p a b e d any a d e ng an DEVIASI ?
HASIL UJI DILUAR SPESIFIKASI
VS DEVIASI
Pengertian Deviasi
• Setiap pelanggaran atau ketidaksesuaian dengan persyaratan dalam dokumen
GMP atau persyaratan peraturan dan/atau merupakan peristiwa yang
berpotensi mempengaruhi kualitas produk, bahan baku atau bahan pengemas.
Investigasi di Lab
LAPORAN PENYIMPANGAN/DEVIASI
INVESTIGASI OOS
Harus dilihat jenis mikroba yang tumbuh, apakah pernah ditemukan sebelumnya,
apakah ada kemungkinan dari lingkungan? Perlu dilakukan identifikasi mikroba.
Umumnya sampel yang sama belum tentu tersedia, terutama apabila kontaminasi
tidak terjadi diseluruh batch.
OOS
Sampling Ulang
Case Study 1 :
Analyst performed an Assay testing for batch XXX of Product
Phase 1 investigation reveals, no issues with batch but there may be something wrong with
Instrument.
Further Instrumental error related investigation reveals that pressure fluctuations during
the sample injection under investigation.
This clearly demonstrates laboratory error and not a confirmed OOS. However only re-
training to analyst is not sufficient.
Certain facts needs to be verified e.g. Analyst Qualification, Periodic Trainings, Instrument
maintenance, etc.
CASE
Case Study 2 :
Analyst performed Content Uniformity testing of injection suspension for batch XXX of Product B
Result for 2 vials out of 10 found outside specification limits (85% - 115%):
1.Vial 2 – 74.3%,
2.Vial 3 – 82.1%
Preliminary Investigation: Method of analysis was accurate and followed appropriately, SST
found ok, other batches in same sequence found satisfactory results
Phase 1 investigation: Samples were re-injected from same vials and found results 73.9% and
83.0% respectively.
Phase 1 investigation reveals, no laboratory error and needs full scale investigation.
Phase 2 investigation reveals batch took long time to finish filling operations than usual.
Operator was interviewed and found that there was error in stirring operation which took little
long to complete the filling operation. However there was no deviation raised and vials
filled before were not separated from good product.
Further investigation reveals that there is no initial check for stirrer before start of operation.
Also there is no provision to record stirrer speed during filling operation.
This clearly demonstrates that, it’s a confirmed OOS due rejected vials passed into good products. There i
TUGAS
Analis melakukan uji kadar air produk A menggunakan karl fisher dan
diperoleh hasil :
1. 8.9%,
2. 2.5% (Spesifikasi ≤ 5%)
Fakta :
Kadar air semua bahan baku dibawah 5%.
Produksi dilakukan di area dengan RH dibawah 25% .
Karl fisher dalam range kalibrasi.
Reagen kalibrasi baru pertama kali dibuka dan belum ED.
Sample disimpan dalam desikator (2 hari).
1. Titik PW 01
2. Titik PW 02
Fakta :
E.Coli negatif pada titik PW 03, PW 04 dan PW 05 .
Sampling dan pengujian dilakukan di hari yang sama
Pengambilan sampel di PW 01 dan PW 02 menggunakan selang yang
sama dengan produksi, di titik PW 03 , PW 04 dan PW 05 diambil
tanpa selang.
Kontrol negatif media juga negatif
Botol sampel disterilisasi dengan autoclave
Lakukan investigasi untuk mencari kemungkinan root cause
Kirimkan ke email : Paling lambat 14 Nov 2021